Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Systematic Review
100%
Meta-Analysis
100%
Randomized Controlled Trial
75%
Therapy Effect
60%
Recurrent Disease
60%
Prostate Specific Antigen
50%
Neurinoma
50%
NLR Family Pyrin Domain containing 3
50%
Interstitial Cystitis
50%
Cystalgia
50%
Pain
50%
Signal Transduction
50%
Lipopolysaccharide
50%
Regional Anesthesia
50%
General Anesthesia
50%
Extracorporeal Shockwave Therapy
50%
Neuroendocrine Differentiation
50%
Cystadenoma
50%
Nephroureterectomy
50%
Ureter Injury
50%
Postoperative Complication
50%
Bladder Cancer
50%
Contralateral
50%
Cancer Growth Factor
50%
Hyperthermia
50%
Mitomycin
50%
NLRP3 Inflammasome
41%
Chemotherapy
40%
Bladder Tissue
33%
Curcumin
33%
Transitional Cell Carcinoma
33%
Interleukin 1
33%
Bladder
33%
Non Muscle Invasive Bladder Cancer
30%
Chronic Inflammation
25%
Erectile Dysfunction
21%
Erectile Function
21%
Tumor
20%
Recurrence Free Survival
20%
Survival Rate
20%
Recurrence Risk
20%
Adverse Event
20%
Case Presentation
18%
Conservative Treatment
16%
Bladder Injury
16%
Fibrosis
16%
Urologic Oncology
16%
Anatomical Concepts
16%
Obstruction
16%
Pathogenesis
16%
Pharmacology, Toxicology and Pharmaceutical Science
Therapeutic Effect
60%
Recurrent Disease
50%
Bladder Cancer
50%
Mitomycin
50%
Hyperthermia
50%
Cancer Growth Factor
50%
Pain
50%
Interstitial Cystitis
50%
Cystalgia
50%
Lipopolysaccharide
50%
Inflammasome
41%
Chemotherapy Regimens
40%
Curcumin
33%
Interleukin 1
33%
Non Muscle Invasive Bladder Cancer
30%
Chronic Inflammation
25%
Survival Rate
20%
Adverse Event
20%
Recurrence Free Survival
20%
Recurrence Risk
20%
Bladder Injury
16%
Fibrosis
16%
Pathogenesis
16%
Tumor Recurrence
10%
Progression Free Survival
10%
Uvomorulin
8%
Myofibrosis
8%
Diseases
8%
Protamine Sulfate
8%
Bladder Dysfunction
8%
Pyrin
8%
Table Salt
8%
Inflammation
8%
Vimentin
8%
Treatment Group
8%
Biochemistry, Genetics and Molecular Biology
Hepatocyte Nuclear Factor 1
100%
Binding Protein
60%
Genetic Divergence
55%
Messenger RNA
50%
Insulin-Like Growth Factor 2
50%
Missense
50%
Nuclear Factor I A
50%
P53
50%
DNA Damage
50%
Homeobox
50%
Single-Nucleotide Polymorphism
44%
Enzyme
20%
Tumor Progression
20%
Genotyping
16%
Gleason Score
16%
Prostate-Specific Antigen
11%
TaqMan
11%
DNA Methyltransferase
10%
Mitochondrion
10%
Synapsin I
10%
phosphorylation
10%
Acetylation
10%
Positive Feedback
10%
Posttranslational Modification
10%
Overall Survival
10%
Ferroptosis
10%
G1/S Transition
10%
Programmed Cell Death
10%
Monoamine Neurotransmitter
10%
In Silico Study
10%
Lipid Peroxidation
10%
Tumor Volume
10%
Intron
5%
Carcinogenesis
5%
RNA
5%
Case-Control Study
5%
Transcription Factors
5%
Tumor Marker
5%
Biomarker Discovery
5%
